...
首页> 外文期刊>Journal of chemotherapy >The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus
【24h】

The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus

机译:利福昔明亚抑制浓度对肺炎克雷伯菌、奇异变形杆菌、铜绿假单胞菌和金黄色葡萄球菌表达的脲酶产生和其他毒力因子的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Rifaximin, a topical derivative of rifampin, inhibited urease production and other virulence factors at sub-MIC concentrations in strains involved in hepatic encephalopathy and the expression of methicillin resistance in Staphylococcus aureus. In particular, urease production was affected in all Proteus mirabilis and Klebsiella pneumoniae strains as well as in all tested Pseudomonas aeruginosa isolates. Other exotoxins, synthesized by P. aeruginosa, such as protease, gelatinase, lipase, lecithinase and DNAse were also not metabolized in the presence of rifaximin. This antibiotic inhibited pigment production in both P. aeruginosa and Chromobacterium violaceum, a biosensor control strain. Lastly, rifaximin affected haemolysin production in S. aureus and was able to restore cefoxitin susceptibility when the strain was cultured in the presence of sub-MICs of the drug. The present findings confirm and extend previous observations about the beneficial effects of rifaximin for the treatment of gastrointestinal diseases, since in this anatomic site, it reaches a large array of concentrations which prevents enterobacteria from thriving and/or producing their major virulence factors.
机译:利福昔明是利福平的外用衍生物,在涉及肝性脑病的菌株中以亚MIC浓度抑制脲酶和其他毒力因子的产生,并抑制金黄色葡萄球菌中甲氧西林耐药性的表达。特别是,所有奇异变形杆菌和肺炎克雷伯菌菌株以及所有测试的铜绿假单胞菌分离株的脲酶生产都受到影响。铜绿假单胞菌合成的其他外毒素,如蛋白酶、明胶酶、脂肪酶、卵磷脂酶和DNA酶,在利福昔明存在下也没有代谢。这种抗生素抑制了铜绿假单胞菌和紫罗兰色杆菌(一种生物传感器对照菌株)的色素产生。最后,利福昔明影响了金黄色葡萄球菌中溶血素的产生,并且当该菌株在药物的亚MIC存在下培养时,能够恢复头孢西丁的敏感性。目前的研究结果证实并扩展了先前关于利福昔明治疗胃肠道疾病的有益作用的观察结果,因为在这个解剖部位,它达到了大量的浓度,阻止了肠杆菌的茁壮成长和/或产生其主要毒力因子。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号